Can CRISPR-Cas gene editing tech fight antimicrobial resistance?
New Delhi, April 28 (IANS) CRISPR-Cas, the Nobel Prize-winning gene-editing technology, has the potential to target resistance genes and make bacteria sensitive to first-line antibiotics again, according to a study.